Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol

Septic shock still has a high mortality rate which has not hinted at decreasing in recent years. Unfortunately, randomized trials failed mainly because the septic patient was considered as a homogeneous entity. All this creates a sort of therapeutic impotence in everyday clinical practice in treatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Busani, Stefano, Roat, Erika, Tosi, Martina, Biagioni, Emanuela, Coloretti, Irene, Meschiari, Marianna, Gelmini, Roberta, Brugioni, Lucio, De Biasi, Sara, Girardis, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930614/
https://www.ncbi.nlm.nih.gov/pubmed/33681248
http://dx.doi.org/10.3389/fmed.2021.616511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930614/
https://www.ncbi.nlm.nih.gov/pubmed/33681248
http://dx.doi.org/10.3389/fmed.2021.616511

Ejemplares similares